Cargando…
Positive p53 Expression Is Associated with Primary Endocrine Therapy Resistance in Locally Advanced Stage Luminal B HER2-Negative Breast Cancer Patients: A Cross-Sectional Study in Indonesia
Luminal B HER2-negative breast cancer (BC) is the most common type in Indonesian BC patients, and frequently manifests with locally advanced staging. Recurrence often occurs within two years of the endocrine therapy course (primary endocrine therapy (ET) resistance). p53 mutation often exists in lum...
Autores principales: | Halim, Freda, Azhar, Yohana, Suwarman, Suwarman, Wahjoepramono, Eka Julianta, Hernowo, Bethy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252228/ https://www.ncbi.nlm.nih.gov/pubmed/37296690 http://dx.doi.org/10.3390/diagnostics13111838 |
Ejemplares similares
-
p53 Mutation as Plausible Predictor for Endocrine Resistance Therapy in Luminal Breast Cancer
por: Halim, Freda, et al.
Publicado: (2022) -
Programmed death ligand-1 protein expression difference in basal like and non-basal like triple negative breast cancer and its association with disease free survival and overall survival: A systematic review
por: Halim, Freda, et al.
Publicado: (2021) -
Immunoexpression of P63 and SOX2 in triple-negative breast cancers, Indonesia
por: Kamarlis, Reno K, et al.
Publicado: (2018) -
Private healthcare initiatives in developing countries – Building sustainable neurosurgery in Indonesia and Pakistan
por: Khan, Tariq, et al.
Publicado: (2023) -
Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19–systematic review, meta-analysis, and meta-regression
por: Pranata, Raymond, et al.
Publicado: (2020)